Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bio-Techne Cp (TECH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,254,140
  • Shares Outstanding, K 37,460
  • Annual Sales, $ 563,000 K
  • Annual Income, $ 76,090 K
  • 36-Month Beta 0.75
  • Price/Sales 9.32
  • Price/Cash Flow 27.75
  • Price/Book 5.45

Price Performance

See More
Period Period Low Period High Performance
1-Month
127.21 +10.31%
on 12/26/17
141.29 -0.69%
on 01/16/18
+10.81 (+8.35%)
since 12/15/17
3-Month
121.26 +15.71%
on 11/13/17
141.29 -0.69%
on 01/16/18
+16.98 (+13.77%)
since 10/17/17
52-Week
95.68 +46.66%
on 02/07/17
141.29 -0.69%
on 01/16/18
+41.26 (+41.65%)
since 01/17/17

Most Recent Stories

More News
Advanced Immunolabeling Reagents and Tools from Vector Laboratories Now from Bio-Techne

Bio-Techne now offers reagents and kits from Vector Laboratories, a leader in advanced labeling and detection solutions. Their innovative proprietary immunolabeling kits offer reliable, sensitive, and...

TECH : 140.56 (+0.21%)
Bio-Techne Acquires Atlanta Biologicals Inc.

Bio-Techne Corporation (NASDAQ: TECH) announced today that it has acquired all of the stock of Atlanta Biologicals, Inc. and its affiliated company, Scientific Ventures, Inc.. The transaction is financed...

TECH : 140.56 (+0.21%)
Bio-Techne To Present At The 36th Annual J.P. Morgan Healthcare Conference

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, and Jim Hippel, Chief Financial Officer will present at the 36th Annual J.P. Morgan Healthcare...

TECH : 140.56 (+0.21%)
JPM : 112.63 (+0.32%)
Bio-Techne's RNAscope® Technology Enabling Robust Gene Expression and Biomarker Analysis Advances Wide-ranging Research with over 1000 Publications

Advanced Cell Diagnostics (ACD), a Bio-Techne brand, is celebrating a milestone in the adoption of its RNAscope® in situ hybridization (ISH) technology. Reaching 1,000 publications and increasing to an...

TECH : 140.56 (+0.21%)
Bio-Techne Offers Updated Novus Panel Builder, Facilitating Multicolor Flow Cytometry Panel Design

Bio-Techne updated its Flow Cytometry Panel Builder tool in July 2017 to support the use of its vast selection of over 18,000 conjugated antibodies, across targets and colors. The Flow Cytometry Panel...

TECH : 140.56 (+0.21%)
Bio-Techne Awards 40,000 USD Research Grant to Innovative Cancer Researcher

Advanced Cell Diagnostics (ACD), a Bio-Techne brand, has announced the winner of its 'RNAscope ISH Get Hybridized' giveaway, designed to recognize and support groundbreaking research with RNAscope® in...

TECH : 140.56 (+0.21%)
Featured Company News - Japanese Patent Office Issued New Patent to Alexion Pharma's Soliris; Extending Patent Protection into 2027

Research Desk Line-up: Bio-Techne Post Earnings Coverage

TECH : 140.56 (+0.21%)
ALXN : 122.22 (-1.82%)
Bio-Techne to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / October 31, 2017 / Bio-Techne (NASDAQ: TECH) will be discussing their earnings results in their Q1 Earnings Call to be held on October 31, 2017 at 9:00 AM Eastern Time.

TECH : 140.56 (+0.21%)
Bio-Techne Declares Dividend

Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2017. The quarterly dividend will be payable...

TECH : 140.56 (+0.21%)
Bio-Techne Releases First Quarter Fiscal 2018 Results

Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the first quarter ended September 30, 2017.

TECH : 140.56 (+0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising...

See More

Key Turning Points

2nd Resistance Point 142.03
1st Resistance Point 141.14
Last Price 140.56
1st Support Level 139.53
2nd Support Level 138.80

See More

52-Week High 141.29
Last Price 140.56
Fibonacci 61.8% 123.87
Fibonacci 50% 118.49
Fibonacci 38.2% 113.10
52-Week Low 95.68

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.